Pacemaker infection due to Vibrio alginolyticus.
Floch
François
F
Clinique Cardiologique, Centre Hospitalier Universitaire de Nantes, Nantes, France.
Boutoille
David
D
D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001267:Atlantic Ocean; D002443:Ceftriaxone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005839:Gentamicins / Q000008:administration & dosage; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D013550:Swimming; D016896:Treatment Outcome; D014735:Vibrio Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D044149:Vibrio alginolyticus / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002443:Ceftriaxone